Home/Filings/4/0001104659-20-131373
4//SEC Filing

Bradshaw Curt 4

Accession 0001104659-20-131373

CIK 0001173281other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 9:46 AM ET

Size

5.9 KB

Accession

0001104659-20-131373

Insider Transaction Report

Form 4
Period: 2020-12-01
Bradshaw Curt
Chief Scientific Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2020-12-01+250,000250,000 total
    Exercise: $7.61Exp: 2030-12-01Common stock (250,000 underlying)
Footnotes (1)
  • [F1]1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

Related Parties

1
  • filerCIK 0001794633

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 9:46 AM ET
Size
5.9 KB